Theracalcium

CONTRA INDICATIONS
Do not use in animals with heart disorders.

ADVERS EEFFECTS
During intramuscular or subcutaneous administration, local tissue reactions at the injection site may be observed. Too rapid intravenous administration can cause cardiac arrhythmia and lead to fatal collapse. Symptoms of hypercalcaemia can occur during the 30 minutes after administration (tremors , excitation sweating , hypotonia and collapse).

SPECIAL WARNINGS
Special warnings for each target species : None.
Special precautions for use in animals : The solution must be warmed to body temperature before administration . Intravenous administration must beslow, and stopped immediately if side effects occur . During intramuscular or subcutaneous administration, divide the dose between several injection sites to limit local reactions.
The use and reuse of this product must undergo benefit/risk evaluation depending on possible previous treatments ,in particular calcium based treatments.
Special precautions to be taken by the person administering the medicinal product to animals
None.
Use during pregnancy or lactation: The safety of the medicinal product has not been evaluated in the target species during pregnancy and lactation . However, the use of the medicinal product during pregnancy and lactation does not pose a particular problem.

Interactions : None known.

Overdose : See ” Adverse effects “section.
Incompatibilities: Compatibility with another medicinal product must be checked before mixing to prevent precipitate from forming.

STORAGE CONDITIONS
Shelf-life after first opening : 28days
Do not store above25°C.
Keep out of reach of children.

WITHDRAWAL PERIOD
Meat and offal : Zero days.
Milk : Zero hours.

SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED VETERINARY MEDICINAL PRODUCT OR WASTE MATERIALS
DERIVED FROM THE USE OF SUCH PRODUCTS
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal product should be disposed of in accordance with local regulations.